LENZ Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
LENZ Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q3 2021 to Q3 2024.
  • LENZ Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending September 30, 2024 was $361K, a 95.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)

LENZ Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $361K -$8.13M -95.7% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $361K -$8.13M -95.7% Jun 30, 2024 10-Q 2024-08-14
Q3 2023 $8.49M +$8.49M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.49M +$8.49M Jun 30, 2023 10-Q 2023-08-14
Q4 2022 $375K $0 0% Dec 31, 2022 10-K 2023-03-20
Q3 2022 $0 -$384K -100% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 Jun 30, 2022 10-Q 2022-08-11
Q4 2021 $375K Dec 31, 2021 10-K 2022-03-21
Q3 2021 $384K Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.